Abiopharma

New Form 424B5 - Monte Rosa Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001193125-26-006297 Size: 657 KB

Ribeiro Ramiro 🟡 adjusted position in 42.5K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.10 ($1.2M) Transaction Date: Jan 05, 2026 | Filing ID: 000004

📋 ERIC J LOUMEAU (Officer) plans to sell 8K shares of ANAPTYSBIO, INC. (at $45.69 each, total $348K) Filed: Jan 07, 2026 | ID: 000228

New Form DEFA14A - ARTELO BIOSCIENCES, INC. Filed: 2026-01-07 AccNo: 0001640334-26-000049 Size: 510 KB

📋 Devers Shannon L. (Officer) plans to sell 9K shares of IONIS PHARMACEUTICALS INC (at $84.68 each, total $795K) Filed: Jan 07, 2026 | ID: 000017

New Form 253G1 - Dare Bioscience, Inc. Filed: 2026-01-07 AccNo: 0001493152-26-000804 Size: 636 KB

New Form D - Dermata Therapeutics, Inc. Filed: 2026-01-07 AccNo: 0001493152-26-000797 Size: 14 KB

(99% Neutral) INOTIV, INC. (NOTV) Files Form 8-K

Director MAETZOLD DEREK J 🔴 sold 4.0K shares of CASTLE BIOSCIENCES INC (CSTL) at $40.10 Transaction Date: Jan 05, 2026 | Filing ID: 001161

Ku Victor 🔴 sold 36.0K shares of Butterfly Network, Inc. (BFLY) at $3.82 Transaction Date: Jan 05, 2026 | Filing ID: 000002

LEONARD JOHN M 🔴 sold 34.1K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006294

(99% Neutral) BiomX Inc. (PHGE) Announces Business Combination

(99% Neutral) GridAI Technologies Corp. (ENTO) Files Form 8-K

Arcus Biosciences - Arcus Outlines 2026 Plans for Casdatifan, its Potential Best-in-Class HIF-2a Inhibitor, and its Inflammation Programs

Schultes Birgit C 🔴 sold 8.5K shares of Intellia Therapeutics, Inc. (NTLA) at $9.21 Transaction Date: Jan 05, 2026 | Filing ID: 006292